Long Island City, NY · Founded 2014 · Privately Held (backing)
Developer of a bioinformatics platform designed to accelerate the development of novel therapeutics. Envisagenics is based in Long Island City, NY and was founded in 2014. Its last known valuation is $150 million. It has raised $40.5 million across 2 recorded rounds; the latest was a $19.2 million early-stage round in Sep 2021.
Last price · $/share
—
Implied valuation
$150.0M
Total raised
$40.5M
Last round
Early Stage VC
Sep 2021
No prints on record
No secondary trades in Envisagenics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Envisagenics with a free account
·The complete investor list: 24 names
·Watch Envisagenics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Envisagenics stock.
